Navigation Links
Drug Company-Funded Asthma Drug Studies More Positive
Date:10/23/2007

Expert review finds fewer adverse effects reported

TUESDAY, Oct. 23 (HealthDay News) -- Drug company-funded studies of asthma drugs called inhaled corticosteroids are less likely to find adverse effects than studies that were paid for by other sources, Spanish researchers say.

A team from Children's Hospital La Fe in Valencia analyzed 504 studies of the drugs conducted between 1993 and 2002.

Potentially harmful decreases in the stress hormone cortisol, decreases in bone mineral density, and growth suppression are among the adverse effects that have been associated with inhaled corticosteroids, the researchers note.

Of the 504 studies, 275 were funded by drug companies and 229 were funded by other sources, such as government agencies and non-profit organizations.

The researchers found that 34.5 percent of drug company-funded studies and 65.1 percent of studies funded by other sources identified significant differences in adverse events between patients who took inhaled corticosteroids and those in control groups who didn't take the drugs.

The researchers said the difference was no longer statistically significant when they factored in components of study design, such as dosage amounts or a focus limited to specific adverse effects. This suggests that the association between funding source and more positive findings may be the result of variations in how the studies were designed, said the researchers.

They noted that it's difficult to determine if drug company-funded studies are too positive or whether studies funded by other sources are too cautious.

Still, "having information on source of funding will help readers of these studies have a better informed and balanced judgment on the authors' interpretations," they concluded. "Disclosure of conflicts of interest should be strengthened for a more balanced opinion of the safety of drugs."

The study appears in the Oct. 22 issue of the journal Archives of Internal Medicine.

More information

The American Lung Association has more about asthma medications.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Oct. 22, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. New Drug for Bronchial Asthma
2. Asthma may actually be prevented by Dust and Dirt
3. Inhaled Steroids Safe & Effective for Children with Asthma
4. What happens when Asthmatics consume Aspirin?
5. Fireworks can spell death for asthmatic children
6. New vaccine helps allergy and asthma patients
7. New vaccine helps allergy and asthma patients
8. Nearly all asthma deaths preventable
9. Asthma! A new warning for heart disease
10. Soluble IL-4 Receptor - A new boon for asthmatics
11. Cats to protect children from asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... Mt. Angel Vitamins, ... a months-long rebranding effort. This includes the introduction of new packaging and messaging, ... market research, we learned that a simple, proactive approach to wellness is important ...
(Date:3/27/2017)... ... March 27, 2017 , ... From 1999 ... alone responsible for over 33,000 of the 52,404 drug-related deaths in 2015.(2) To ... 1512, which proposes a tax on prescription opioids to fund drug rehabilitation and ...
(Date:3/26/2017)... , ... March 26, 2017 , ... ... to receive the RealSelf 100 Award, a prestigious award honoring the top influencers ... and to find and connect with doctors and clinics. , In 2016, more ...
(Date:3/24/2017)... ... 2017 , ... Clean Earth, Inc., a leader in providing ... materials announced today the acquisition of privately owned AERC Recycling Solutions ... facilities and a vast array of additional technologies, services, and new markets to ...
(Date:3/24/2017)... NY (PRWEB) , ... March 24, 2017 , ... ... scale; from third world countries to hospitals in the United States, it’s a ... conversation on the current obstacles facing infection prevention and offers strategies for the ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017  Sanderling Ventures, portfolio company, Torax ... division of Johnson & Johnson. Torax manufactures and markets ... of gastro-esophageal reflux disease (GERD). The LINK device ... and the procedure is currently available in the ... Medical was founded by Sanderling Ventures, Mayo Medical ...
(Date:3/27/2017)... 27, 2017 BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today that AGI-134, an immunotherapy for the treatment of multiple ... will be featured at the upcoming American Association for ... DC to be held on April 1-5, 2017. ... An ...
(Date:3/27/2017)... 2017 The global clinical ... billion by 2025, according to a new study by ... diseases is anticipated to be responsible for the high ... the scope for growth during the forecast period. In ... is highly susceptible to chronic diseases, is presumed to ...
Breaking Medicine Technology: